Safe Orthopaedics Posts 3Q18 Revenue Growth of 20%
Safe Orthopaedics posted 3Q18 revenue of ‚¬0.8MM (~US $0.9MM), +20% vs. 3Q17, with YTD18 revenue of ‚¬2.4MM (~$2.8M), +7% vs....
Oct 09, 2018,
Safe Orthopaedics Posts 3Q18 Revenue Growth of 20%
Corin Acquiring Global Orthopaedic Technology
Corin signed a binding agreement to acquire Global Orthopaedic Technology, manufacturer of hip and knee replacement devices in Australia....
Oct 05, 2018,
OMNIlife science Achieves 1,000 OMNIBotics Active Spacer Robotic-Assisted TKRs
OMNIlife science has completed >1,000 robotic-assisted TKR procedures utilizing the OMNIBotics® Active Spacer....
Oct 04, 2018,
ApiFix System Reaches 250-Patient Milestone in Scoliosis Correction
The ApiFix Minimally Invasive Deformity Correction (MID-C) technology for correction of Adolescent Idiopathic Scoliosis has been used in 250 patients...
Oct 04, 2018,
Paragon 28 Continues to Expand Baby Gorilla Mini Plating System
Paragon 28 launched Medial and Lateral Talar Neck fracture plates and additional plates for its Baby Gorilla Mini Plating System....
Oct 04, 2018,
Trice Medical Adds Ultrasound Capability to mi-eye Direct Visualization Platform
Trice Medical launched mi-ultra, a high-powered handheld ultrasound transducer optimized for musculoskeletal applications for use at the first point of...
Oct 03, 2018,
SI-BONE Announces UK Guidance Recommendation for iFuse
The U.K.'s National Institute for Health and Care Excellence published medical technology guidance recommending SI-BONE's iFuse® for the treatment of chronic sacroiliac joint pain....
Oct 03, 2018,
Amedica Closes Sale of Spine Portfolio to CTL Medical
Amedica completed the sale of its spine business to CTL Medical, which is now exclusive owner of the metal and silicon nitride...
Oct 03, 2018,
Bone Solutions Completes 250 Cases with OsteoCrete Bone Void Filler
Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler....
Oct 02, 2018,
Bioventus Signs Pfizer as Exclusive DUROLANE Distributor in Brazil
Bioventus received ANVISA approval to market DUROLANE® single-injection in Brazil to treat hip osteoarthritis. Pfizer will serve as its exclusive...
Oct 02, 2018,
Loading new posts...
No more posts
